annual SGA:
$9.78B+$832.47M(+9.31%)Summary
- As of today (May 29, 2025), NVO annual SGA is $9.78 billion, with the most recent change of +$832.47 million (+9.31%) on December 31, 2024.
- During the last 3 years, NVO annual SGA has risen by +$3.24 billion (+49.63%).
- NVO annual SGA is now at all-time high.
Performance
NVO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$2.27B-$626.36M(-21.61%)Summary
- As of today (May 29, 2025), NVO quarterly SGA is $2.27 billion, with the most recent change of -$626.36 million (-21.61%) on March 31, 2025.
- Over the past year, NVO quarterly SGA has increased by +$172.18 million (+8.20%).
- NVO quarterly SGA is now -21.61% below its all-time high of $2.90 billion, reached on December 31, 2024.
Performance
NVO quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$74.40B+$5.59B(+8.13%)Summary
- As of today (May 29, 2025), NVO TTM SGA is $74.40 billion, with the most recent change of +$5.59 billion (+8.13%) on March 31, 2025.
- Over the past year, NVO TTM SGA has increased by +$65.30 billion (+717.91%).
- NVO TTM SGA is now at all-time high.
Performance
NVO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVO Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.3% | +8.2% | +717.9% |
| 3 y3 years | +49.6% | +35.0% | +1009.4% |
| 5 y5 years | +82.0% | +80.7% | +1270.3% |
NVO Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.6% | -21.6% | +35.0% | at high | +81.6% |
| 5 y | 5-year | at high | +82.0% | -21.6% | +87.0% | at high | +126.8% |
| alltime | all time | at high | +9860.2% | -21.6% | +479.7% | at high | >+9999.0% |
NVO Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.27B(-21.6%) | $9.94B(+1.8%) |
| Dec 2024 | $9.78B(+9.3%) | $2.90B(+18.5%) | $9.77B(+2.2%) |
| Sep 2024 | - | $2.45B(+5.3%) | $9.56B(+4.3%) |
| Jun 2024 | - | $2.32B(+10.6%) | $9.17B(+0.8%) |
| Mar 2024 | - | $2.10B(-21.9%) | $9.10B(+1.7%) |
| Dec 2023 | $8.94B(+24.5%) | $2.69B(+30.8%) | $8.94B(+7.4%) |
| Sep 2023 | - | $2.06B(-8.8%) | $8.33B(+4.4%) |
| Jun 2023 | - | $2.25B(+15.9%) | $7.98B(+7.5%) |
| Mar 2023 | - | $1.94B(-6.3%) | $7.42B(+3.7%) |
| Dec 2022 | $7.19B(+10.0%) | $2.07B(+21.5%) | $7.16B(+1.5%) |
| Sep 2022 | - | $1.71B(+0.8%) | $7.06B(+1.4%) |
| Jun 2022 | - | $1.69B(+0.7%) | $6.96B(+3.7%) |
| Mar 2022 | - | $1.68B(-14.7%) | $6.71B(+3.0%) |
| Dec 2021 | $6.53B(+15.6%) | $1.97B(+22.6%) | $6.51B(+3.4%) |
| Sep 2021 | - | $1.61B(+11.4%) | $6.30B(+2.7%) |
| Jun 2021 | - | $1.44B(-3.1%) | $6.13B(+3.9%) |
| Mar 2021 | - | $1.49B(-15.2%) | $5.90B(+4.1%) |
| Dec 2020 | $5.65B(+5.2%) | $1.76B(+21.8%) | $5.67B(+2.9%) |
| Sep 2020 | - | $1.44B(+18.7%) | $5.51B(+2.5%) |
| Jun 2020 | - | $1.21B(-3.4%) | $5.38B(-1.0%) |
| Mar 2020 | - | $1.26B(-21.3%) | $5.43B(+1.1%) |
| Dec 2019 | $5.37B(+1.8%) | $1.60B(+22.2%) | $5.37B(+1.3%) |
| Sep 2019 | - | $1.31B(+3.0%) | $5.30B(+0.9%) |
| Jun 2019 | - | $1.27B(+6.1%) | $5.25B(-0.1%) |
| Mar 2019 | - | $1.20B(-21.8%) | $5.25B(-0.2%) |
| Dec 2018 | $5.28B(+7.9%) | $1.53B(+21.6%) | $5.26B(+0.7%) |
| Sep 2018 | - | $1.26B(-1.2%) | $5.23B(+1.7%) |
| Jun 2018 | - | $1.27B(+5.4%) | $5.14B(+2.9%) |
| Mar 2018 | - | $1.21B(-19.0%) | $4.99B(+2.1%) |
| Dec 2017 | $4.89B(+1.7%) | $1.49B(+27.5%) | $4.89B(+3.7%) |
| Sep 2017 | - | $1.17B(+3.7%) | $4.71B(-0.3%) |
| Jun 2017 | - | $1.13B(+2.1%) | $4.73B(-1.0%) |
| Mar 2017 | - | $1.10B(-16.2%) | $4.77B(-0.6%) |
| Dec 2016 | $4.81B(+0.4%) | $1.32B(+11.4%) | $4.80B(-0.7%) |
| Sep 2016 | - | $1.18B(+0.5%) | $4.84B(+0.1%) |
| Jun 2016 | - | $1.18B(+3.9%) | $4.83B(-0.4%) |
| Mar 2016 | - | $1.13B(-16.2%) | $4.85B(+1.5%) |
| Dec 2015 | $4.79B(+0.3%) | $1.35B(+14.7%) | $4.78B(+1.1%) |
| Sep 2015 | - | $1.18B(-1.4%) | $4.73B(-0.6%) |
| Jun 2015 | - | $1.19B(+12.6%) | $4.76B(+0.6%) |
| Mar 2015 | - | $1.06B(-18.4%) | $4.73B(-0.4%) |
| Dec 2014 | $4.77B(-0.3%) | $1.30B(+8.0%) | $4.75B(-1.6%) |
| Sep 2014 | - | $1.20B(+3.1%) | $4.83B(+1.6%) |
| Jun 2014 | - | $1.17B(+8.0%) | $4.76B(+0.1%) |
| Mar 2014 | - | $1.08B(-21.6%) | $4.75B(-0.8%) |
| Dec 2013 | $4.79B(+11.5%) | $1.38B(+22.2%) | $4.79B(+2.8%) |
| Sep 2013 | - | $1.13B(-3.1%) | $4.66B(+2.4%) |
| Jun 2013 | - | $1.16B(+4.0%) | $4.55B(+3.0%) |
| Mar 2013 | - | $1.12B(-10.3%) | $4.42B(+3.0%) |
| Dec 2012 | $4.29B | $1.25B(+22.7%) | $4.29B(+2.5%) |
| Sep 2012 | - | $1.02B(-1.4%) | $4.19B(-0.6%) |
| Jun 2012 | - | $1.03B(+4.1%) | $4.21B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $992.02M(-13.2%) | $4.22B(+1.7%) |
| Dec 2011 | $4.16B(+9.8%) | $1.14B(+9.3%) | $4.15B(+2.9%) |
| Sep 2011 | - | $1.05B(+0.1%) | $4.04B(+2.6%) |
| Jun 2011 | - | $1.04B(+13.5%) | $3.93B(+5.3%) |
| Mar 2011 | - | $920.28M(-10.2%) | $3.73B(+1.3%) |
| Dec 2010 | $3.78B(+11.2%) | $1.03B(+8.7%) | $3.69B(+2.2%) |
| Sep 2010 | - | $943.37M(+11.6%) | $3.61B(+3.9%) |
| Jun 2010 | - | $845.64M(-3.1%) | $3.47B(+0.9%) |
| Mar 2010 | - | $873.00M(-7.7%) | $3.44B(+2.9%) |
| Dec 2009 | $3.40B(+9.2%) | $945.33M(+17.1%) | $3.34B(+2.8%) |
| Sep 2009 | - | $807.16M(-0.9%) | $3.25B(+1.7%) |
| Jun 2009 | - | $814.67M(+4.8%) | $3.20B(+0.5%) |
| Mar 2009 | - | $777.37M(-9.1%) | $3.18B(+2.3%) |
| Dec 2008 | $3.12B(+13.8%) | $855.36M(+13.7%) | $3.11B(+3.1%) |
| Sep 2008 | - | $752.01M(-5.7%) | $3.02B(+2.9%) |
| Jun 2008 | - | $797.24M(+12.9%) | $2.93B(+4.5%) |
| Mar 2008 | - | $706.36M(-7.2%) | $2.81B(+2.3%) |
| Dec 2007 | $2.74B(+16.2%) | $761.31M(+14.0%) | $2.74B(+2.8%) |
| Sep 2007 | - | $667.56M(-0.5%) | $2.67B(+4.0%) |
| Jun 2007 | - | $670.85M(+4.2%) | $2.57B(+3.9%) |
| Mar 2007 | - | $643.69M(-6.4%) | $2.47B(+8.1%) |
| Dec 2006 | $2.36B(+19.7%) | $687.64M(+21.8%) | $2.29B(+6.1%) |
| Sep 2006 | - | $564.58M(-1.8%) | $2.16B(+4.0%) |
| Jun 2006 | - | $574.78M(+25.1%) | $2.07B(+5.8%) |
| Mar 2006 | - | $459.45M(-17.5%) | $1.96B(-0.1%) |
| Dec 2005 | $1.97B(+14.4%) | $556.96M(+15.5%) | $1.96B(+1.9%) |
| Sep 2005 | - | $482.02M(+4.3%) | $1.93B(+3.5%) |
| Jun 2005 | - | $462.04M(+0.0%) | $1.86B(+3.9%) |
| Mar 2005 | - | $461.96M(-11.2%) | $1.79B(+3.6%) |
| Dec 2004 | $1.72B(+16.9%) | $520.51M(+24.7%) | $1.73B(+43.1%) |
| Sep 2004 | - | $417.37M(+6.5%) | $1.21B(+52.8%) |
| Jun 2004 | - | $391.82M(-1.9%) | $791.13M(+98.1%) |
| Mar 2004 | - | $399.31M | $399.31M |
| Dec 2003 | $1.47B(+22.8%) | - | - |
| Dec 2002 | $1.20B(+10.1%) | - | - |
| Dec 2001 | $1.09B(+10.7%) | - | - |
| Dec 2000 | $983.27M(+7.8%) | - | - |
| Dec 1999 | $911.84M(+13.8%) | - | - |
| Dec 1998 | $801.53M(-12.2%) | - | - |
| Dec 1997 | $912.47M(-31.2%) | - | - |
| Dec 1996 | $1.33B(+8.0%) | - | - |
| Dec 1995 | $1.23B(+14.7%) | - | - |
| Dec 1994 | $1.07B(+73.4%) | - | - |
| Dec 1993 | $616.94M(-40.9%) | - | - |
| Dec 1992 | $1.04B(+119.3%) | - | - |
| Dec 1991 | $476.29M(+11.6%) | - | - |
| Dec 1990 | $426.67M(+33.5%) | - | - |
| Dec 1989 | $319.57M(+29.8%) | - | - |
| Dec 1988 | $246.13M(+10.3%) | - | - |
| Dec 1987 | $223.06M(+103.6%) | - | - |
| Dec 1985 | $109.57M(+11.6%) | - | - |
| Dec 1984 | $98.15M | - | - |
FAQ
- What is Novo Nordisk A/S annual SGA?
- What is the all time high annual SGA for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual SGA year-on-year change?
- What is Novo Nordisk A/S quarterly SGA?
- What is the all time high quarterly SGA for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly SGA year-on-year change?
- What is Novo Nordisk A/S TTM SGA?
- What is the all time high TTM SGA for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM SGA year-on-year change?
What is Novo Nordisk A/S annual SGA?
The current annual SGA of NVO is $9.78B
What is the all time high annual SGA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual SGA is $9.78B
What is Novo Nordisk A/S annual SGA year-on-year change?
Over the past year, NVO annual SGA has changed by +$832.47M (+9.31%)
What is Novo Nordisk A/S quarterly SGA?
The current quarterly SGA of NVO is $2.27B
What is the all time high quarterly SGA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly SGA is $2.90B
What is Novo Nordisk A/S quarterly SGA year-on-year change?
Over the past year, NVO quarterly SGA has changed by +$172.18M (+8.20%)
What is Novo Nordisk A/S TTM SGA?
The current TTM SGA of NVO is $74.40B
What is the all time high TTM SGA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM SGA is $74.40B
What is Novo Nordisk A/S TTM SGA year-on-year change?
Over the past year, NVO TTM SGA has changed by +$65.30B (+717.91%)